Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kirschfink

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Immunological Reviews|June 21, 2001
Targeting complement in therapyM Kirschfink
Deutsche Medizinische Wochenschrift (1946)|August 4, 1995
[Pharmacological effects on the complement system. Possibilities and limitations of anti-inflammatory therapy]M Kirschfink
Deutsche Medizinische Wochenschrift (1946)|March 4, 1994
[Disorders of the complement system: clinical aspects and diagnosis]M Kirschfink
Immunopharmacology|February 26, 1998
Controlling the complement system in inflammationM Kirschfink
Methods in Molecular Medicine|March 11, 2011
ImmunoblottingM Kirschfink, P Terness
Molecular Immunology|March 1, 1987
Augmentation of hemolytic efficiency of anti-hapten IgG antibody by anti-IgG antibody is primarily the function of the anti-hapten IgGM Kirschfink, T Borsos
Molecular Immunology|July 14, 1999
C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical applicationM Kirschfink, W Nürnberger
Journal of Thrombosis and Haemostasis : JTH|June 20, 2014
Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysisC Wehling, M Kirschfink
Molecular Immunology|May 1, 1988
Binding and activation of C4 and C3 on the red cell surface by non-complement enzymesM Kirschfink, T Borsos
Immunitat Und Infektion|April 1, 1995
[Pharmacological modulation of the complement system: an opportunity for successful xenotransplantation]B Heckl-Ostreicher, M Kirschfink
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Immunological Reviews|June 21, 2001
Targeting complement in therapyM Kirschfink
Deutsche Medizinische Wochenschrift (1946)|August 4, 1995
[Pharmacological effects on the complement system. Possibilities and limitations of anti-inflammatory therapy]M Kirschfink
Deutsche Medizinische Wochenschrift (1946)|March 4, 1994
[Disorders of the complement system: clinical aspects and diagnosis]M Kirschfink
Immunopharmacology|February 26, 1998
Controlling the complement system in inflammationM Kirschfink
Methods in Molecular Medicine|March 11, 2011
ImmunoblottingM Kirschfink, P Terness
Molecular Immunology|March 1, 1987
Augmentation of hemolytic efficiency of anti-hapten IgG antibody by anti-IgG antibody is primarily the function of the anti-hapten IgGM Kirschfink, T Borsos
Molecular Immunology|July 14, 1999
C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical applicationM Kirschfink, W Nürnberger
Journal of Thrombosis and Haemostasis : JTH|June 20, 2014
Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysisC Wehling, M Kirschfink
Molecular Immunology|May 1, 1988
Binding and activation of C4 and C3 on the red cell surface by non-complement enzymesM Kirschfink, T Borsos
Immunitat Und Infektion|April 1, 1995
[Pharmacological modulation of the complement system: an opportunity for successful xenotransplantation]B Heckl-Ostreicher, M Kirschfink
Pageof 11